Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|October 6, 2006
Breast cancer expression profiling: the impact of microarray testing on clinical decision makingOlga Modlich, Hans-Bernd Prisack, Hans BojarCancer Genetics and Cytogenetics|December 31, 2002
Analysis of BRCA1, TP53, and TSG101 germline mutations in German breast and/or ovarian cancer familiesVera Balz, Hans Bernd Prisack, Henning Bier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2004
Immediate gene expression changes after the first course of neoadjuvant chemotherapy in patients with primary breast cancer diseaseOlga Modlich, Hans-Bernd Prisack, Marc Munnes, et al.Journal of Translational Medicine|August 11, 2005
Predictors of primary breast cancers responsiveness to preoperative epirubicin/cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signaturesOlga Modlich, Hans-Bernd Prisack, Marc Munnes, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 27, 2002
Gene expression profiling of advanced head and neck squamous cell carcinomas and two squamous cell carcinoma cell lines under radio/chemotherapy using cDNA arraysKarl Axel Hartmann, Olga Modlich, Hans Bernd Prisack, et al.Anticancer Research|December 13, 2005
Predictive biological markers for response of invasive breast cancer to anthracycline/cyclophosphamide-based primary (radio-)chemotherapyHans-Bernd Prisack, Christiaan Karreman, Olga Modlich, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profilesOlga Modlich, Hans-Bernd Prisack, Gerald Pitschke, et al.Journal for Immunotherapy of Cancer|January 10, 2023
Tumor-infiltrating lymphocytes mediate complete and durable remission in a patient with NY-ESO-1 expressing prostate cancerJulia Karbach, Dragan Kiselicki, Kathrin Brand, et al.Cancer Gene Therapy|April 8, 2003
Novel cGMP liposomal vectors mediate efficient gene transferGernot Röder, Oliver Keil, Hans-Bernd Prisack, et al.Cancer Gene Therapy|January 9, 2004
Non-small lung cancer cells are prime targets for p53 gene transfer mediated by a recombinant adeno-associated virus type-2 vectorUlrich-Peter Rohr, Marc-Andre Wulf, Susanne Stahn, et al.Pageof 1